TOI insider buying
2 cluster buysOncology Institute, Inc.
When two or more insiders at Oncology Institute, Inc. buy TOI in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in TOI plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Mar 13 – May 20, 2026Detected May 20, 20262 insidersTotal bought$2.2MMarket cap$543.9M
- Mar 26 – Mar 26, 2025Detected Mar 26, 2025Executive buyer8 insidersTotal bought$1.6MMarket cap$543.9M
All notable open-market buys in TOI
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jul 21, 2026 | 10% Owner | 18,000 | $5.27 | $94.9K | SEC ↗ |
| Jul 10, 2026 | 10% Owner | 15,000 | $5.85 | $87.8K | SEC ↗ |
| May 20, 2026 | Chernett Joreycluster 10% Owner | 33,500 | $4.07 | $136.3K | SEC ↗ |
| May 19, 2026 | Chernett Joreycluster 10% Owner | 30,000 | $4.09 | $122.7K | SEC ↗ |
| Mar 27, 2026 | Chernett Joreycluster 10% Owner | 27,429 | $2.96 | $81.2K | SEC ↗ |
| Mar 26, 2026 | Chernett Joreycluster 10% Owner | 50,000 | $3.15 | $157.5K | SEC ↗ |
| Mar 24, 2026 | Chernett Joreycluster 10% Owner | 125,000 | $3.11 | $388.8K | SEC ↗ |
| Mar 20, 2026 | Chernett Joreycluster 10% Owner | 25,000 | $3.35 | $83.8K | SEC ↗ |
| Mar 17, 2026 | Chernett Joreycluster 10% Owner | 75,000 | $3.42 | $256.5K | SEC ↗ |
| Mar 16, 2026 | Chernett Joreycluster 10% Owner | 60,985 | $3.29 | $200.6K | SEC ↗ |
| Mar 13, 2026 | Chernett Joreycluster 10% Owner | 263,000 | $2.92 | $768.0K | SEC ↗ |
| Mar 26, 2025 | BARASCH RICHARD Acluster Director | 1,358,448 | $1.04 | $1.4M | SEC ↗ |
| Mar 26, 2025 | Pacala Mark Lcluster Director | 90,562 | $1.04 | $94.2K | SEC ↗ |
| Mar 26, 2025 | Johnson Karen Mariecluster Director | 36,224 | $1.04 | $37.7K | SEC ↗ |
| Mar 26, 2025 | Virnich Danielcluster Chief Executive Officer | 22,640 | $1.04 | $23.5K | SEC ↗ |
| Mar 26, 2025 | Podnos Yalecluster Chief Medical Officer | 9,056 | $1.04 | $9.4K | SEC ↗ |
| Mar 26, 2025 | Castle Jeremycluster Chief Operating Officer | 9,056 | $1.04 | $9.4K | SEC ↗ |
| Mar 26, 2025 | Hively Bradcluster Director | 9,056 | $1.04 | $9.4K | SEC ↗ |
| Mar 26, 2025 | Carter Robert Rosscluster Chief Financial Officer | 9,056 | $1.04 | $9.4K | SEC ↗ |
| Dec 2, 2024 | Director | 50,000 | $0.15 | $7.5K | SEC ↗ |
| Nov 26, 2024 | Director | 250,000 | $0.17 | $42.5K | SEC ↗ |
TOI insider buying — FAQ
- Are insiders buying TOI stock?
- Yes — 10 distinct insiders have bought TOI (Oncology Institute, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Jul 22, 2026.
- How much TOI stock have insiders bought?
- Insiders have bought a combined $4.0M of TOI across 21 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in TOI?
- A cluster buy is two or more distinct Oncology Institute, Inc. insiders — officers, directors, or 10% owners — each buying TOI on the open market within a rolling window. TOI has 2 detected cluster buys to date.
- Where does this TOI insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in TOI
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy TOI within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding TOI.